Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60637


Purpose:

The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids (ICS) vs. placebo in adults with chronic stable asthma.


Criteria:

Inclusion criteria: - Physician diagnosis of asthma. - Age ≥18 years and ≤50 years - Evidence of airflow obstruction as measured by spirometry and flow-volume loop per American Thoracic Society guidelines. - Treatment for asthma with: - daily inhaled corticosteroids and long-acting beta2-agonists, AND - as-needed use of a short-acting beta2-agonist Exclusion criteria: - History of >10 pack-year tobacco use - Other pulmonary or cardiac diagnosis that is actively being treated - History of adverse events or allergy to fluticasone - Systemic corticosteroid therapy within 7 days of study visit - Inability to obtain written informed consent


NCT ID:

NCT00695604


Primary Contact:

Principal Investigator
Jerry Krishnan, MD, PhD
University of Illinois at Chicago


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60637
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.